H.R. 5585 · 117th Congress

ARPA–H Act

Introduced on Oct 15, 2021 by Anna G. Eshoo (D-CA-18). 66 cosponsors, 3 of them from another party. Latest action (Jun 23, 2022): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Stage
Passed one chamber
Introduced
Oct 15, 2021
Cosponsors
66
3 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To establish the Advanced Research Projects Agency-Health, and for other purposes.

Subjects

  • Advisory bodies
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Executive agency funding and structure
  • Federal officials
  • Government information and archives
  • Government studies and investigations
  • Health care costs and insurance
  • Health technology, devices, supplies
  • Public contracts and procurement
  • Research administration and funding
  • Research and development
  • Technology transfer and commercialization

Summary

By the Congressional Research Service (Passed House, Jun 22, 2022). Public domain.

Advanced Research Projects Agency-Health Act or the ARPA-H Act

This bill establishes within the Department of Health and Human Services (HHS) the Advanced Research Projects Agency-Health to accelerate health and medical innovation by investing in high-risk, high-reward research. The bill also establishes a committee to advise on agency activities.

HHS must transfer all authorities, functions, funds, and personnel from a similar entity within the National Institutes of Health to a new, independent agency.

Additionally, the President must appoint a director to lead the agency. The director may submit testimony and recommendations concerning the agency to Congress without review or approval by other federal officers or agencies.

The director must appoint personnel to administer the agency's research programs, including by selecting projects to support and making recommendations about terminating or continuing projects.

The agency may use grants, prize competitions, and a variety of other mechanisms to support the research projects. The agency's budget is separate from that of HHS.

The agency must coordinate with the Food and Drug Administration and the Centers for Medicare & Medicaid Services to expedite development and coverage of high-need cures. Additionally, the agency may partner with other public and private entities (e.g., institutions of higher education and patient advocacy organizations).

The bill also requires the agency to develop and periodically update a strategic plan and annually report on its activities. Furthermore, (1) the National Academies of Sciences, Engineering, and Medicine must evaluate the agency's performance; and (2) the Government Accountability Office must review the research portfolio of HHS and its components, including the new agency.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Anna G. EshooD-CA-18Sponsor

Democrats · 63

Republicans · 3

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

  1. On Agreeing to the Amendment
    Jun 22, 2022· House· Amendments· Agreed to 381–40
  2. On Passage
    Jun 22, 2022· House· Passage· Passed 336–85

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Oct 15, 2021Introduced in House
  2. Oct 15, 2021Introduced in House
  3. Oct 15, 2021 · HouseReferred to the House Committee on Energy and Commerce.
  4. Oct 18, 2021 · HouseReferred to the Subcommittee on Health.
  5. May 11, 2022 · HouseSubcommittee Consideration and Mark-up Session Held.
  6. May 11, 2022 · HouseForwarded by Subcommittee to Full Committee by Voice Vote .
  7. May 18, 2022 · HouseCommittee Consideration and Mark-up Session Held.
  8. May 18, 2022 · HouseOrdered to be Reported (Amended) by the Yeas and Nays: 53 - 3.
  9. Jun 13, 2022Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-365.
  10. Jun 13, 2022 · HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-365.
  11. Jun 13, 2022 · HousePlaced on the Union Calendar, Calendar No. 277.
  12. Jun 21, 2022 · HouseRules Committee Resolution H. Res. 1191 Reported to House. Rule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.
  13. Jun 22, 2022 · HouseConsidered under the provisions of rule H. Res. 1191. (consideration: CR H5795-5803; text: CR H5795-5798)
  14. Jun 22, 2022 · HouseRule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.
  15. Jun 22, 2022 · HouseDEBATE - The House proceeded with one hour of debate on H.R. 5585.
  16. Jun 22, 2022 · HouseDEBATE - Pursuant to the provisions of H. Res. 1170, the House proceeded with 10 minutes of debate on the Eshoo amendment No. 1.
  17. Jun 22, 2022 · HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the Eshoo amendment, the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mrs. Boebert demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
  18. Jun 22, 2022 · HousePursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would be postponed.
  19. Jun 22, 2022 · HousePursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would resume.
  20. Jun 22, 2022 · HouseConsidered as unfinished business. (consideration: CR H5808-5809)
  21. Jun 22, 2022Passed/agreed to in House: On passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).House · Roll call 288
  22. Jun 22, 2022 · HouseOn passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).House · Roll call 288
  23. Jun 22, 2022 · HouseMotion to reconsider laid on the table Agreed to without objection.
  24. Jun 23, 2022 · SenateReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.